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Abstract
Background: Our study aimed to determine whether the consideration of socio-demographic features improves
the prediction of Alzheimer’s dementia (AD) at 5 years when using the Free and Cued Selective Reminding Test
(FCSRT) in the general older population.
Methods: Our analyses focused on 2558 subjects from the prospective Three-City Study, a cohort of community-
dwelling individuals aged 65 years and over, with FCSRT scores. Four “residual scores” and “risk scores” were built that
included the FCSRT scores and socio-demographic variables. The predictive performance of crude, residual and risk
scores was analyzed by comparing the areas under the ROC curve (AUC).
Results: In total, 1750 subjects were seen 5 years after completing the FCSRT. AD was diagnosed in 116 of them.
Compared with the crude free-recall score, the predictive performances of the residual score and of the risk score were
not significantly improved (AUC: 0.83 vs 0.82 and 0.88 vs 0.89 respectively).
Conclusion: Using socio-demographic features in addition to the FCSRT does not improve its predictive performance
for dementia or AD.
Keyword: Dementia, Prediction, Alzheimer disease, prodromal Alzheimer disease, preclinical Alzheimer disease, Early
clinical trial
Background
The early identification of preclinical forms of Alzhei-
mer’s disease (AD) has been the focus of much research
over the last two decades. Indeed, because the AD
pathophysiological process begins several years or de-
cades before the clinical diagnosis [1–3], it seems more
promising, for treating the disease, to act upstream of
the clinical stage, before the installation of irreversible
damage [4]. The development of such therapies requires
the early identification of patients with AD at the prede-
mentia stage. In accordance with these conceptual
advances, AD diagnosis has been redefined recently in
the context of research. It now requires, for its typical
form, the combination of amnesic syndrome of hippo-
campal type and a pathophysiological AD biomarker,
such as cerebrospinal fluid proteins (decreased Aβ42
and increased T-tau and P-tau) or amyloid plaques de-
tected by PET imaging with a specific tracer [5]. How-
ever, the measurement of such biomarkers cannot be
generalized to the entire population because of the po-
tential side effects of the used methods (exposure to ra-
diation for brain imaging; pain and risks related to
invasive procedures for cerebrospinal fluid collection)
and because of their ever-increasing cost [6]. A possible
alternative could be a large screening using a noninva-
sive and cheap tool [7], such as a neuropsychological
test. The Free and Cued Selective Reminding Test
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(FCSRT) [8], which has been recommended for assessing
amnesic syndrome of hippocampal type [5, 9], could be
potentially useful in this context. Indeed, in a first study
conducted in general population [10], the FCSRT exhib-
ited good sensitivity and specificity for AD prediction at
5 years (92% and 64% respectively for the FCSRT free re-
call), but showed a poor positive predictive value of
about 8%.
To our knowledge, no study has tried to improve the
predictive performances of a neuropsychological test by
combining the test results with some readily available in-
formation, such as socio-demographic data. Socio-
demographic features (sex, age and education) strongly
influence cognitive scores [11–16] and the dementia risk
[17]. Combining these characteristics with the results of
an episodic memory test could therefore improve de-
mentia prediction. Two types of algorithm can be used
for this prediction. The predictive information contained
in socio-demographic variables can be added to the
neuropsychological test score to generate a predictive
“risk score”, built according to the recommendations of
the international literature [18]. Alternatively, an algo-
rithm can be developed to allow the interpretation of
the neuropsychological test scores as a function of the
socio-demographic characteristics. A “residual score”
can thus be calculated that corresponds to the difference
between the observed and the expected scores for a
subject of a given sex, age and education level. Such
a “residual score” was recently proposed by Reed et
al. [19] for quantifying the cognitive reserve [20] from
the scores of an episodic memory test after removing
the variability due to socio-demographic factors and
level of brain pathology.
The objective of this study was therefore to determine
whether the addition of socio-demographic factors to
the FCSRT score to generate a risk score or the use of a
residual score could improve the prediction of dementia
and/or AD at 3 and 5 years compared with the FCSRT
crude scores alone, in a population-based cohort of older
subjects.
Methods
Population and study design
Data were extracted from the multi-site prospective
Three-City Study (3C) cohort study on 9294
community-dwelling persons aged 65 years and over re-
cruited from the electoral rolls of three French cities be-
tween 1999 and 2001 [21]. The 3C protocol was
approved by the Ethical Committee of the University
Hospital of Bicêtre (France) and written informed con-
sent was obtained from each participant. Socio-
demographic characteristics, health status and lifestyle
information were collected using standardized question-
naires during face-to-face interviews. Subjects were seen
again at 2 years (S1), 4 years (S2), 5 years (S3), 7 years
(S4), 10 years (S5) and 12 years (S6) after inclusion. Be-
cause the FCSRT was administered only to participants
from the Montpellier and Bordeaux 3C centers at the S4
visit, the current study used data for 2558 subjects from
these two cities who were nondemented and completed
the cognitive tests at S4 (baseline of our analyses).
Among these subjects, 459 were excluded (170 dead and
289 lost to follow-up between S4 and S5) for the predic-
tion of dementia at 3 years after FCSRT completion, and
808 (351 dead and 457 lost to follow-up between S4 and
S6) for the prediction of dementia at 5 years after the
FCSRT (Fig. 1).
FCSRT administration and scores
The French version [22] of the FCSRT [8, 22] was ad-
ministered at S4 for the first time in the Montpellier
center and for the second time in the Bordeaux center.
The test assesses verbal episodic memory. The neuro-
psychological test begins with an encoding phase during
which the patient has to learn 16 words, four at a time
(presented on a card). Each word belongs to a different
semantic category. The subject is asked to say the name
of the item corresponding to a specific semantic cat-
egory (e.g., “what is the name of this fruit?”). After all
four items are identified correctly, the card is removed
and their immediate cued recall is tested by present-
ing the cues again in order to control for encoding.
Once the immediate recall of a group of four items is
completed, the next set of four items is presented.
After the encoding phase is completed, the participant
is asked to recall as many words as possible in 2 mi-
nutes (free recall). The neuropsychologist then pro-
vides a cue (word category) for each nonretrieved
word to help the patient recalling the remaining
words. Free and cued recalls are repeated three times.
The delayed recall phase is performed 20 minutes
later, also with a free and a cued recall.
For our analyses, we used the “free recall score” (sum
of the number of words retrieved at the three free recall
trials), the “total recall score” (sum of the three free +
cued recall trials) (both scores range from 0 to 48), the
“delayed free recall score” (number of words retrieved at
the delayed free recall trial) and the “delayed total recall
score” (free + cued delayed recall trial) (both scores
range from 0 to 16).
Diagnosis of dementia
Dementia was diagnosed in two steps at each follow-up
visit. Subjects at risk were identified by the 3C neuro-
psychologist on the basis of the results of the Mini-
Mental State Examination (MMSE) [23] and the Isaacs
set test (IST) [24]. The IST, consisting of generating
words belonging to four semantic categories (cities,
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fruits, animals and colors) in 15 seconds, measured se-
mantic verbal fluency ability. These participants were
then examined by a 3C physician who confirmed or not
the diagnosis and severity of the disease. The physician
was blind to the FCSRT scores. Finally, all diagnoses
were reviewed by a panel of five neurologists, independ-
ent of the 3C investigators. The panel examined all avail-
able information, including the FCSRT scores, and
agreed on the presence or absence of dementia, accord-
ing to the DSM-IV TR criteria [25], and on its etiology
using the National Institute of Neurological and Com-
municative Disorders and Stroke–Alzheimer's Disease
and Related Disorders Association criteria [26] for prob-
able and possible AD. When we further analysed the
prediction of AD, subjects with a diagnosis of non-AD
dementia were not excluded but were included in a
group which contained both patients without dementia
and patients with non-AD dementia.
Statistical analysis
The participants’ characteristics were described using
frequency and proportion for categorical variables and
mean and standard deviation (SD) for continuous vari-
ables. Comparisons between groups were performed
using the Student’s t test for the FCSRT scores and the
chi-square test for percentages of missing data (subjects
who did not begin or complete the FCSRT at S4).
To construct the FCSRT “residual scores”, the crude
scores were modeled using linear regression models that
included, as independent variables, age, age-squared, sex
and education level (primary school: 0–5 years of educa-
tion; vocational school certificate; French junior-school dip-
loma; French high-school diploma; graduate studies). The
total proportion of variance of the crude scores explained
by the linear model was expressed using the coefficient of
determination, denoted R2. The estimated beta coefficients
were used to generate the estimated FCSRT scores for each
individual. The “residual scores” were then defined and
computed as the difference between the estimated and the
crude FCSRT scores. Consequently, the variability of these
“residual scores” corresponds to the FCSRT residual vari-
ance after removing the part of variance associated with
the socio-demographics variables [19].
The dementia and AD “risk scores” were constructed
using a logistic regression model. The probability of de-
mentia or AD at 3 and 5 years (S5 and S6 visits) after
FCSRT completion, and between these two visits, was
modeled as a function of the FCSRT crude scores, age,
sex, education level and interaction between the FCSRT
crude scores and the three socio-demographic character-
istics (age, sex and education level). Regression coeffi-
cients were used to compute a risk score for each
subject. To avoid over-fitting, the risk scores were evalu-
ated using cross-validation methods by splitting the sam-
ple into two, according to the inclusion center [27].
Fig. 1 Study flow chart. AD Alzheimer’s disease, FCSRT Free and Cued Selective Reminding Test, S4 visit with FCRST administration, S5 3 years
after FCRST administration, S6 5 years after FCRST administration
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Thus, the risk score coefficients were estimated using
only the Bordeaux data (training dataset) because of the
larger number of patients with dementia in this center.
The risk score predictive performances were evaluated
using the Montpellier data (testing dataset). A sensibility
analysis was conducted by inverting the cities for the
training and testing dataset.
The performance of the “crude scores”, “residual
scores” and “risk scores” for the prediction of dementia
and AD at 3 and 5 years, and between 3 and 5 years,
was assessed using receiver operating curve (ROC) ana-
lysis [28]. The area under the curve (AUC) values were
compared using the nonparametric method described by
DeLong et al. [29].
Analyses were performed with a bilateral alpha level of
0.05 using SAS software, version 9.1 (SAS Institute,
Cary, NC, USA).
Results
At the S4 follow-up visit (baseline of our analyses), the
mean age of the 2558 participants was 80 years (SD:
4.7), 63.8% were women, 27.3% had 0–5 years of educa-
tion, 17.0% had a French junior-school diploma (9 years
of education), 11.1% had a vocational school certificate
(10–11 years of education), 14.9% had a French high-
school diploma (12 years of education) and 29.7% had a
graduate diploma (at least 14 years of education).
At S5 (3 years after FCSRT completion) 90 participants
had developed dementia (AD n = 57), and at S7 (5 years
after FCSRT completion) the cumulative number of inci-
dent cases of dementia (over the 3 and 5 years) was 173
(AD n = 116).
The coefficients of the linear regressions used to pro-
duce the expected FCSRT scores according to age, age-
squared, sex and level of education are shown in Add-
itional file 1: Table S1. These models explained from R2
= 4.5% to R2 = 10.6% of the total variance of the different
FCSRT scores. The “crude scores”, the “residual scores”
(differences between crude and estimated FCSRT scores)
and the percentage of “refusal or abandon” (subjects
who did not begin or complete the neuropsychological
test at S4) relative to the occurrence of dementia and
AD at 3 and 5 years are presented in Table 1. Compari-
sons of the AUC for the ROC curves of the crude and
residual scores (Table 2 and Fig. 2a, b) showed that,
compared with the crude scores, the residual scores did
not improve the prediction of dementia or AD occur-
rence at 3 or 5 years, and between 3 and 5 years, which-
ever FCSRT score was considered.
The construction of the “risk scores” was based on the
beta coefficients from logistic regression analyses per-
formed using the Bordeaux center data (training data-
set). Each risk score included a given FCSRT score, age,
sex, education level and the interaction between these
three variables and the FCSRT score. Coefficients of lo-
gistic regression used for the construction of risk scores
are shown in Additional file 2: Table S2. The perfor-
mances of the risk scores for the prediction of dementia
or AD were evaluated using the Montpellier center data
(testing dataset) (as recommended in [27]). Comparison
of the AUC for the risk scores vs crude scores showed
that the risk scores did not improve the prediction of
dementia and AD at 3 and 5 years, and between 3
and 5 years (Table 3). The sensibility analysis con-
ducted by inverting the cities for the training and
testing dataset led to the same conclusion (data not
shown).
Discussion
Here, we show that the use of “risk scores” or “residual
scores” that take into account sex, age and education
level does not improve the FCSRT performance for the
prediction of dementia and AD at 3 and 5 years com-
pared with the crude FCSRT scores. Therefore, the
FCSRT on its own, without the addition of socio-
demographic data, is sufficient for the prediction of de-
mentia and AD in the general population.
Our study has several strengths. First, we conducted
this analysis on data from the 3C trial, a large cohort of
older subjects recruited from the general population in
France. This enabled us to have sufficient numbers of
patients who developed dementia or AD during the
follow-up for a prediction study that included a cross-
validation of the risk scores. Second, we used the FCSRT
[8]. This neuropsychological test is recommended for
assessing amnesic syndrome of hippocampal type [5]
and has been frequently reported to be efficient also in
the context of AD detection and prediction [9, 30–32].
In agreement, our study confirmed the previous results
on FCSRT prediction of dementia in the Bordeaux co-
hort of the 3C [10] and showed the better performance
of the free recall score for the prediction of dementia
and AD, as reported also by the GuidAge study in pa-
tients with memory complaints [30]. We used in this
study the validated French version of the FCRST [22]
which has been used in most French studies analyzing
the FCRST (PREAL study [9], Three-City Study [10] or
CONSTANCES study [16]). This version differs from
the original version in the presentation, during the en-
coding phase of the test, with cards displaying words
(4 × 4) adapted to the French-speaking population rather
than cards displaying pictures. In two French studies
[9, 10] which have determined a cutoff value to predict
dementia, these values were lower than the one pro-
posed by Grobber et al. [33]. More precisely, Sarazin et
al. [9] proposed a free recall score ≤ 17 for the prediction
of AD at 3 years in MCI subjects, whereas Grobber et al.
[33] proposed a score ≤ 24 to identify very mild dementia
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in primary care. Furthermore, Auriacombe et al. [10]
proposed a free recall score ≤ 16 for the prediction of de-
mentia at 2 years, and a score ≤ 24 for the prediction at
5 years in the general population. This means that the
French version of the test is calibrated on a more diffi-
cult basis than the original version, and explains why
subjects who became demented during our study appear
to have an initial FCSRT score similar to the scores of
a
b
Fig. 2 ROC curves representing the FCSRT crude and residual scores for the prediction of Alzheimer's disease at a 3 years and b 5 years AUC area
under the curve, FCSRT Free and Cued Selective Reminding Test
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already demented patients in the publication by Grober
et al. [33].
A point which could be raised concerning the predic-
tion performances of the “residual scores” is the part of
the variance explained by socio-demographics factors.
This part varies from 10.6% for the free recall score to
4.5% for the delayed total recall score. These percentages
are consistent with figures published in the general
population [16]. The smaller amount of explained vari-
ance for the total recall and delayed total recall scores
can be explained by the ceiling effect that affects these
two scores. Indeed, if a large number of subjects have
the maximum score, the part of variance that might be
explained by socio-demographic factors is automatically
reduced. Conversely, the free recall and delayed free re-
call scores do not exhibit a ceiling effect. Another ex-
planation could be the relative homogeneity of our
sample (all subjects were older than 70 years) that did
not allow fully capturing the cognitive variability be-
tween younger and older subjects.
In our study, 7–8% of participants did not complete
the FCSRT test. This should not be considered a limita-
tion of the study. Indeed, the interruption or refusal dur-
ing the execution of a test is a reality that cannot be
avoided in clinical practice. Moreover, our data indicate
that almost one-third of noncompleters developed AD
in the next 3 years (Table 1). This behavior could there-
fore be considered a risk factor for AD. This result is
consistent with a previous publication showing that re-
fusing neuropsychological tests is associated with poorer
cognitive functioning [34].
For this study, we did not have access to postmortem
data to confirm the diagnosis of AD or dementia. Never-
theless, all diagnoses were reviewed by a panel of inde-
pendent experts who had access to all data, including the
FCSRT scores. Consequently, the clinical diagnoses and
FCSRT results were not independent, which could have
overestimated FCSRT predictive performance. However, it
is unlikely that this potential classification bias influenced
the comparison of the crude, residual and risk scores.
Moreover, for AD prediction, we grouped subjects with
other dementia types in the non-AD group, together with
nondemented subjects. This choice might have decreased
FCSRT predictive performance, but should not have influ-
enced the comparison between scores.
Concerning the risk scores, their construction and as-
sessment using the same dataset generally leads to over-
fitting the model and overestimating their performances.
Therefore, we split our data into two datasets, based on
the inclusion center (Bordeaux and Montpellier), for
their construction and cross-validation, as recommended
by Altman et al. [27]. This analysis showed that the risk
scores did not predict dementia or AD better than the
crude scores.
The absence of improvement of the test predictive per-
formances when the socio-demographic variables are
taken into account could also bring new insight into the
question of the cognitive reserve. Reed et al. [19] sug-
gested including socio-demographic factors in a residual
score for AD prediction because they thought that the
neuropsychological test scores should be corrected for
age, sex and education to better measure the cognitive
reserve. Conversely, our results suggest that this is not
the case. Reed et al.’s [19] approach was based on the
hypothesis that the cognitive reserve could be better es-
timated by removing the parts of variability of a neuro-
psychological test due to socio-demographic features
and brain damage load. We did not have information
about the severity of brain damage in our population, a
major issue in their hypothesis [19]. Nonetheless, our re-
sults stress that this hypothesis needs to be further in-
vestigated before being accepted.
Another new finding of our study is that FCSRT crude
scores exhibit good performance for the prediction of
dementia between 3 and 5 years independently of the
cases diagnosed in the first 3 years. Although it may
seem difficult in practice to differentiate subjects who
will convert before and after 3 years, these results ex-
plore the maintenance of performance of the neuro-
psychological test several years after the examination. It
will be interesting in future research to study the predic-
tion of dementia and/or AD even earlier, 5 to 10 years
before the diagnosis of dementia. In this context our re-
sults will not necessarily apply to this issue and will have
to be re-evaluated
A practical implication of our results is that, in the
context of a therapeutic trial concerning the early
stages of dementia/AD (i.e., before the clinical signs/
diagnosis), the FCSRT could be used alone, without
any information about socio-demographic features, to
identify the target population at very high risk of de-
mentia and/or AD. It could be used with a single
threshold (e.g., a free recall score ≤ 22, as proposed by
Auriacombe et al. [10]), without norms by sex, age
and education, despite the strong FCSRT dependence
on these features. In the future, other methods, such
as the simultaneous use of several cognitive scores or
the analysis of FCSRT longitudinal variations during a
repeated follow-up, could be explored to improve
FCSRT predictive performances.
Conclusions
Our study shows that the FCSRT predicts dementia and
AD independently from socio-demographic characteris-
tics, and that the use of this information does not im-
prove prediction of dementia when using FCSRT results
in the general population.
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Additional files
Additional file 1: is Table S1. presenting coefficients for the linear
regression analyzing the relation between FCSRT scores and age, age-
squared, sex and education. (DOCX 20 kb)
Additional file 2: is Table S2. presenting coefficients of logistic
regression used for the construction of risk scores of Alzheimer’s
dementia at 3 years and at 5 years based on age, sex, education, FCSRT
scores and the interaction between socio-demographics factors and
FCSRT scores. (DOCX 29 kb)
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